NASDAQ:RCM

R1 RCM - RCM Stock Forecast, Price & News

$14.56

+0.26 (+1.82%)

(As of 03/27/2023 12:00 AM ET)

Add

Compare

Today's Range: $14.23
▼
$14.65
50-Day Range: $12.42
▼
$14.89
52-Week Range: $6.71
▼
$27.86

Volume: 2.11 million shs
Average Volume: 2.69 million shs
Market Capitalization: $6.07 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $16.85

Institutional Ownership

R1 RCM MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.83 Rating Score
Upside/Downside: 15.7% Upside
$16.85 Price Target
Short Interest: Bearish
9.39% of Float Sold Short
Dividend Strength: N/A
Sustainability: -1.33
Upright™ Environmental Score
News Sentiment: 0.79
Based on 5 Articles This Week
Insider Trading: Acquiring Shares
$999,714 Bought Last Quarter
Proj. Earnings Growth: 138.89%
From $0.18 to $0.43 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.63 out of 5 stars

Business Services Sector

70th out of 328 stocks

Management Services Industry

1st out of 7 stocks

3.4

Analyst's Opinion

Consensus Rating
R1 RCM has received a consensus rating of Buy. The company's average rating score is 2.83, and is based on 10 buy ratings, 2 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $16.85, R1 RCM has a forecasted upside of 15.7% from its current price of $14.56.
Amount of Analyst Coverage
R1 RCM has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

1.0

Short Interest

Percentage of Shares Shorted
9.39% of the float of R1 RCM has been sold short.
Short Interest Ratio / Days to Cover
R1 RCM has a short interest ratio ("days to cover") of 6.7.
Change versus previous month
Short interest in R1 RCM has recently increased by 5.09%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
R1 RCM does not currently pay a dividend.
Dividend Growth
R1 RCM does not have a long track record of dividend growth.

3.6

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
R1 RCM has received a 45.11% net impact score from Upright. R1 Rcm seems to create the most significant positive value in categories "Jobs", "Taxes", and "Physical diseases". The positive contribution in the "Physical diseases" impact category is mostly driven by its "Documentation software for clinicians", "Personal health record software", and "Hospital cost management software" products. See details.
Environmental Sustainability
The Environmental Impact score for R1 RCM is -1.33.

2.7

News and Social Media Coverage

News Sentiment
R1 RCM has a news sentiment score of 0.79. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.54 average news sentiment score of Business Services companies.
News Coverage This Week
MarketBeat has tracked 5 news articles for R1 RCM this week, compared to 3 articles on an average week.
MarketBeat Follows
Only 1 people have added R1 RCM to their MarketBeat watchlist in the last 30 days. This is a decrease of -75% compared to the previous 30 days.

5.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, R1 RCM insiders have bought more of their company's stock than they have sold. Specifically, they have bought $999,714.00 in company stock and sold $0.00 in company stock.
Percentage Held by Insiders
59.40% of the stock of R1 RCM is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
97.09% of the stock of R1 RCM is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.9

Earnings and Valuation

Earnings Growth
Earnings for R1 RCM are expected to grow by 138.89% in the coming year, from $0.18 to $0.43 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of R1 RCM is -104.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of R1 RCM is -104.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Growth Ratio
R1 RCM has a PEG Ratio of 8.24. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
R1 RCM has a P/B Ratio of 2.23. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About R1 RCM (NASDAQ:RCM) Stock

R1 RCM, Inc. engages in the provision of revenue cycle management to healthcare providers. It offers end-to-end, modular revenue cycle, and physician advisory services. The company was founded by Mary Ann Tolan and J. Michael Cline in July 2003 and is headquartered in Murray, UT.

Receive RCM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for R1 RCM and its competitors with MarketBeat's FREE daily newsletter.

RCM Stock News Headlines

March 27, 2023 | marketwatch.com

Healthcare Revenue Cycle Management Software Market by Product Type and Consumers-2031

March 24, 2023 | marketwatch.com

Healthcare Revenue Cycle Management Software Market Trends, Industry Demand and Scope, Top Players Analysis, Forecast 2023 - 2031

March 27, 2023 | Behind the Markets (Ad)

Buy THIS stock before Taiwan is attacked

... If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan's own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself.

March 21, 2023 | uk.finance.yahoo.com

Revenue Cycle Management (RCM) Global Market Report 2023

March 20, 2023 | marketwatch.com

Healthcare Revenue Cycle Management Software Market Latest Innovations and Future Expansion 2023-2029

March 17, 2023 | marketwatch.com

Healthcare Revenue Cycle Management Software Market Size Report till 2029

March 17, 2023 | finance.yahoo.com

Those who invested in R1 RCM (NASDAQ:RCM) five years ago are up 84%

March 17, 2023 | finance.yahoo.com

Q4 2022 Cymabay Therapeutics Inc Earnings Call

March 27, 2023 | Behind the Markets (Ad)

Buy THIS stock before Taiwan is attacked

March 15, 2023 | marketwatch.com

Healthcare Business Process Outsourcing Market Application, Product, Sales and Forecast 2023-2028

March 9, 2023 | marketwatch.com

The Healthcare RCM Outsourcing study investigates the market's expansion over the previous few years and into the foreseeable future.

March 8, 2023 | barrons.com

S&P 500 Futures Rise in Premarket Trading; CrowdStrike Holdings, R1 RCM Lead

March 1, 2023 | finance.yahoo.com

R1 RCM Issues 2022 Environmental, Social, and Governance Report

February 28, 2023 | finance.yahoo.com

R1 RCM (RCM) Faced Multiple Challenges in Q4

February 27, 2023 | marketwatch.com

Revenue Cycle Management Market (New Updated Report) Size and Share Expanding worldwide by 2023-2029 | 60 Pages Report

February 23, 2023 | marketwatch.com

A Closer Look at the Revenue Cycle Management (RCM) System Market (2023 to 2029)-Opportunities and Challenges

February 20, 2023 | finance.yahoo.com

Revenue Cycle Management Software Global Market Report 2023

February 18, 2023 | seekingalpha.com

R1 RCM, Inc. (RCM) Q4 2022 Earnings Call Transcript

February 18, 2023 | finance.yahoo.com

R1 RCM Full Year 2022 Earnings: EPS Misses Expectations

February 17, 2023 | markets.businessinsider.com

Analysts Are Neutral on These Services Stocks: R1 RCM (RCM), Texas Roadhouse (TXRH)

February 16, 2023 | marketwatch.com

R1 RCM Shares Rise 7% After 4Q Revenue Beats Expectations

February 16, 2023 | finance.yahoo.com

Why R1 RCM Stock Is Surging Today

February 16, 2023 | msn.com

R1 RCM GAAP EPS of -$0.09 misses by $0.04, revenue of $532.8M beats by $13.52M

February 16, 2023 | finance.yahoo.com

R1 RCM Reports Fourth Quarter and Full Year 2022 Results

February 16, 2023 | finance.yahoo.com

R1 RCM Inc. (RCM) Reports Q4 Loss, Tops Revenue Estimates

February 15, 2023 | msn.com

R1 RCM Earnings Preview

February 10, 2023 | marketwatch.com

2023, Current Status and Future Prospects Of Revenue Cycle Management (RCM) System Market

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive RCM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for R1 RCM and its competitors with MarketBeat's FREE daily newsletter.

RCM Company Calendar

Last Earnings: 2/16/2023
Today: 3/27/2023
Next Earnings (Estimated): 5/08/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Management services
Sub-Industry: Health Care Services
Sector: Business Services
Current Symbol: NASDAQ:RCM
Previous Symbol: NYSE:RCM
CUSIP: 00438V10
CIK: 1472595
Web: www.r1rcm.com
Phone: (312) 324-7820
Fax: 302-655-5049
Employees: 22,000
Year Founded: 2003

Price Target and Rating

Average Stock Price Forecast: $16.85
High Stock Price Forecast: $25.00
Low Stock Price Forecast: $10.00
Forecasted Upside/Downside: +16.7%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.83
Research Coverage: 12 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.14)
Trailing P/E Ratio: N/A
Forward P/E Ratio: 80.17
P/E Growth: 8.24
Net Income: $-57,600,000.00
Net Margins: -3.19%
Pretax Margin: -3.38%
Return on Equity: 0.05%
Return on Assets: 0.03%

Debt

Debt-to-Equity Ratio: 0.64
Current Ratio: 1.61
Quick Ratio: N/A

Sales & Book Value

Annual Sales: $1.81 billion
Price / Sales: 3.33
Cash Flow: $0.29 per share
Price / Cash Flow: 50.47
Book Value: $6.53 per share
Price / Book: 2.21

Miscellaneous

Outstanding Shares: 416,660,000
Free Float: 169,165,000
Market Cap: $6.01 billion
Optionable: Not Optionable
Beta: 0.82

Social Links

Key Executives

Lee Rivas
Chief Executive Officer & Director

John Sparby
President

Kristina Bourke
Executive Vice President-Operations

Jennifer Williams
Chief Financial Officer & EVP

Harvey Ewing
Chief Information Officer & Executive VP

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

RCM Stock - Frequently Asked Questions

Should I buy or sell R1 RCM stock right now?: 12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for R1 RCM in the last year. There are currently 2 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" RCM shares.
View RCM analyst ratings or view top-rated stocks.
What is R1 RCM's stock price forecast for 2023?: 12 brokerages have issued 12-month price objectives for R1 RCM's shares. Their RCM share price forecasts range from $10.00 to $25.00. On average, they expect the company's stock price to reach $16.85 in the next twelve months. This suggests a possible upside of 16.3% from the stock's current price.
View analysts price targets for RCM or view top-rated stocks among Wall Street analysts.
How have RCM shares performed in 2023?: R1 RCM's stock was trading at $10.95 at the beginning of 2023. Since then, RCM shares have increased by 32.2% and is now trading at $14.48.
View the best growth stocks for 2023 here.
When is R1 RCM's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, May 8th 2023.
View our RCM earnings forecast.
How were R1 RCM's earnings last quarter?: R1 RCM Inc. (NASDAQ:RCM) issued its quarterly earnings data on Thursday, February, 16th. The healthcare provider reported ($0.09) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by $0.06. The healthcare provider earned $532.80 million during the quarter, compared to the consensus estimate of $519.28 million. R1 RCM had a positive trailing twelve-month return on equity of 0.05% and a negative net margin of 3.19%. The business's revenue for the quarter was up 33.6% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.11 earnings per share.
What ETFs hold R1 RCM's stock?: ETFs with the largest weight of R1 RCM (NASDAQ:RCM) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC), Fidelity Digital Health ETF (FDHT), SPDR S&P Health Care Services ETF (XHS), Thrivent Small-Mid Cap ESG ETF (TSME), Pacer Lunt MidCap Multi-Factor Alternator ETF (PAMC), ERShares NextGen Entrepreneurs ETF (ERSX), iShares U.S. Healthcare Providers ETF (IHF) and Invesco NASDAQ Next Gen 100 ETF (QQQJ).
What guidance has R1 RCM issued on next quarter's earnings?: R1 RCM issued an update on its FY 2023 earnings guidance on Friday, February, 24th. The company provided EPS guidance of for the period. The company issued revenue guidance of $2.28 billion-$2.33 billion, compared to the consensus revenue estimate of $2.30 billion.
What is Joseph Flanagan's approval rating as R1 RCM's CEO?: 253 employees have rated R1 RCM Chief Executive Officer Joseph Flanagan on Glassdoor.com. Joseph Flanagan has an approval rating of 70% among the company's employees.

What other stocks do shareholders of R1 RCM own?: Based on aggregate information from My MarketBeat watchlists, some companies that other R1 RCM investors own include NVIDIA (NVDA), JD.com (JD), Baozun (BZUN), Inseego (INSG), BioXcel Therapeutics (BTAI), Marvell Technology (MRVL), Akoustis Technologies (AKTS), Alibaba Group (BABA), Bilibili (BILI) and Model N (MODN).
What is R1 RCM's stock symbol?: R1 RCM trades on the NASDAQ under the ticker symbol "RCM."
Who are R1 RCM's major shareholders?: R1 RCM's stock is owned by a number of institutional and retail investors. Top institutional investors include New Mountain Capital L.L.C. (22.67%), Point72 Asset Management L.P. (2.60%), Sachem Head Capital Management LP (1.63%), American Century Companies Inc. (1.25%), Sunriver Management LLC (1.11%) and Morgan Stanley (1.06%). Insiders that own company stock include Achi Series Lllp Tcp-Asc, Alex Mandl, Gary Steven Long, John M Sparby, Joseph Gerard Flanagan, Lee Rivas, Michael C Feiner and Richard B Jr Evans.
View institutional ownership trends.
How do I buy shares of R1 RCM?: Shares of RCM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is R1 RCM's stock price today?: One share of RCM stock can currently be purchased for approximately $14.48.
How much money does R1 RCM make?: R1 RCM (NASDAQ:RCM) has a market capitalization of $6.03 billion and generates $1.81 billion in revenue each year. The healthcare provider earns $-57,600,000.00 in net income (profit) each year or ($0.14) on an earnings per share basis.
How many employees does R1 RCM have?: The company employs 22,000 workers across the globe.
Does R1 RCM have any subsidiaries?: The following companies are subsidiares of R1 RCM: Accretive Health Mauritius Inc., Cerner RevWorks, Clearsight Intermediate Holdings Inc., Cloudmed, Flare Capital Partners Investment Company, Intermedix, Intermedix ARM LLC, Intermedix Corporation, Intermedix Holdings Inc., Intermedix Lietuva UAB, Intermedix Midco Inc., Intermedix Office Based LLC, Intermedix Staffing Inc., Medical Consultants Inc., Practice Support Resources LLC, Project Links Parent Inc., Project Roadrunner Merger Sub Inc., Project Roadrunner Parent Inc., R1 RCM Global Private Limited, R1 RCM India Private Limited, Rover16 Inc., SCHEDULING.COM INC., SCI Solutions, Tonic Health LLC, VisitPay, cGate Health Inc., and iVinci Partners LLC.
Read More
How can I contact R1 RCM?: R1 RCM's mailing address is 401 NORTH MICHIGAN AVENUE SUITE 2700, CHICAGO IL, 60611. The official website for the company is www.r1rcm.com. The healthcare provider can be reached via phone at (312) 324-7820, via email at arahim@r1rcm.com, or via fax at 302-655-5049.

This page (NASDAQ:RCM) was last updated on 3/27/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

R1 RCM - RCM Stock Forecast, Price & News

R1 RCM MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

Environmental Sustainability

News and Social Media Coverage

News Sentiment

News Coverage This Week

MarketBeat Follows

Company Ownership

Earnings and Valuation

About R1 RCM (NASDAQ:RCM) Stock

RCM Stock News Headlines

RCM Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

Insiders & Institutions

RCM Stock - Frequently Asked Questions

Overall MarketRank^™